Clinical trial Recruiting at 1 site Observational Ages 15 to 49 Women only

Registry for patients with recurrent pregnancy loss

Official title: Prospective Recurrent Pregnancy Loss (ProRPL) Registry

Run by University of British Columbia · NCT05989178 · Data updated 2026-11-12

This study is collecting information from women who have had multiple pregnancy losses to see how different treatments and care options can help them over time.

Quick facts

Study typeObservational
Ages15 Years to 49 Years
SexWomen only
Enrollment3000 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedJuly 12, 2022
Main results expectedDecember 31, 2032
Study endsDecember 31, 2032
Registry record updatedDecember 13, 2024
Trial IDNCT05989178 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women who have experienced two or more pregnancy losses before 20 weeks of gestation.

Probably not a fit

Patients seeking care for reasons other than recurrent pregnancy loss will not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to collect and analyze data from patients experiencing recurrent pregnancy loss at the BC Women's Hospital. It will evaluate investigation practices, treatment options, and outcomes over time through a comprehensive approach that includes patient questionnaires and medical records. The program has been providing specialized care for 15 years and utilizes a collaborative model to support patients with clinical management and education. Data will be gathered from initial visits and follow-up questionnaires for up to five years.

Why it matters

Potential benefit: If successful, this registry could improve understanding and management of recurrent pregnancy loss, leading to better outcomes for affected patients.

How similar studies have gone: Other studies focusing on recurrent pregnancy loss have shown promise in improving patient outcomes, indicating that this approach may also be beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• Patients seen at the BC Women's Recurrent Pregnancy Loss Clinic with recurrent pregnancy loss, defined as ≥2 pregnancy losses before 20 weeks of gestation.

Exclusion Criteria:

• Patients at BC Women's Recurrent Pregnancy Loss Clinic seen for reasons other than recurrent pregnancy loss.

Where it's running

  • BC Women's Hospital & Health Centre
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

  • Principal investigator: Mohamed A. Bedaiwy, MD, PhD — BC Women's Hospital & Health Centre
  • Study coordinator: Mohamed A. Bedaiwy, MD, PhD
  • Email: mohamed.bedaiwy@cw.bc.ca
  • Phone: 604-875-2000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.